Macrogenics (MGNX) Operating Income (2016 - 2025)
Historic Operating Income for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $18.6 million.
- Macrogenics' Operating Income fell 6561.05% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.6 million, marking a year-over-year decrease of 605.92%. This contributed to the annual value of -$110.6 million for FY2024, which is 3427.52% up from last year.
- According to the latest figures from Q3 2025, Macrogenics' Operating Income is $18.6 million, which was down 6561.05% from -$36.8 million recorded in Q2 2025.
- In the past 5 years, Macrogenics' Operating Income registered a high of $54.2 million during Q3 2024, and its lowest value of -$66.6 million during Q1 2022.
- In the last 5 years, Macrogenics' Operating Income had a median value of -$42.6 million in 2025 and averaged -$34.9 million.
- Its Operating Income has fluctuated over the past 5 years, first tumbled by 258368.66% in 2021, then soared by 25264.21% in 2024.
- Macrogenics' Operating Income (Quarter) stood at -$58.2 million in 2021, then soared by 120.58% to $12.0 million in 2022, then plummeted by 511.87% to -$49.4 million in 2023, then decreased by 7.06% to -$52.8 million in 2024, then soared by 135.27% to $18.6 million in 2025.
- Its last three reported values are $18.6 million in Q3 2025, -$36.8 million for Q2 2025, and -$42.6 million during Q1 2025.